These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9399215)
21. Predictors and course of health-related quality of life in Parkinson's disease. Forsaa EB; Larsen JP; Wentzel-Larsen T; Herlofson K; Alves G Mov Disord; 2008 Jul; 23(10):1420-7. PubMed ID: 18512757 [TBL] [Abstract][Full Text] [Related]
22. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]. Jost WH; Klasser M; Reichmann H Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504 [TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nuclei. Just H; Ostergaard K Mov Disord; 2002 May; 17(3):539-45. PubMed ID: 12112204 [TBL] [Abstract][Full Text] [Related]
24. Longitudinal psychometric attributes, responsiveness, and importance of change: An approach using the SCOPA-Psychosocial questionnaire. Martínez-Martin P; Carod-Artal FJ; da Silveira Ribeiro L; Ziomkowski S; Vargas AP; Kummer W; Mesquita HM Mov Disord; 2008 Aug; 23(11):1516-23. PubMed ID: 18649392 [TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation. Straits-Tröster K; Fields JA; Wilkinson SB; Pahwa R; Lyons KE; Koller WC; Tröster AI Brain Cogn; 2000 Apr; 42(3):399-416. PubMed ID: 10753487 [TBL] [Abstract][Full Text] [Related]
26. Effect of exercise on perceived quality of life of individuals with Parkinson's disease. Baatile J; Langbein WE; Weaver F; Maloney C; Jost MB J Rehabil Res Dev; 2000; 37(5):529-34. PubMed ID: 11322151 [TBL] [Abstract][Full Text] [Related]
27. Sense of coherence is a sensitive measure for changes in subjects with Parkinson's disease during 1 year. Caap-Ahlgren M; Dehlin O Scand J Caring Sci; 2004 Jun; 18(2):154-9. PubMed ID: 15147478 [TBL] [Abstract][Full Text] [Related]
29. Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Marras C; McDermott MP; Rochon PA; Tanner CM; Naglie G; Lang AE; Mov Disord; 2008 Apr; 23(5):653-9; quiz 776. PubMed ID: 18076084 [TBL] [Abstract][Full Text] [Related]
30. Factors affecting the quality of life of patients with idiopathic Parkinson's disease--a cross-sectional study in an outpatient clinic attendees. Sławek J; Derejko M; Lass P Parkinsonism Relat Disord; 2005 Nov; 11(7):465-8. PubMed ID: 16154794 [TBL] [Abstract][Full Text] [Related]
31. Testing the validity of the PDQ-39 in patients with MSA. Schrag A; Jenkinson C; Selai C; Mathias C; Quinn N Parkinsonism Relat Disord; 2007 Apr; 13(3):152-6. PubMed ID: 17070089 [TBL] [Abstract][Full Text] [Related]
32. [Neuropsychiatric problems in patients with Parkinson's disease]. Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846 [TBL] [Abstract][Full Text] [Related]
33. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079 [TBL] [Abstract][Full Text] [Related]
34. Whose quality of life? Ethical implications in patient-reported health outcome measurement. Hagell P; Reimer J; Nyberg P Value Health; 2009 Jun; 12(4):613-7. PubMed ID: 19900259 [TBL] [Abstract][Full Text] [Related]
35. Translation and validation of the standard Chinese version of PDQ-39: a quality-of-life measure for patients with Parkinson's disease. Tsang KL; Chi I; Ho SL; Lou VW; Lee TM; Chu LW Mov Disord; 2002 Sep; 17(5):1036-40. PubMed ID: 12360555 [TBL] [Abstract][Full Text] [Related]
36. Fear of falling has greater influence than other aspects of gait disorders on quality of life in patients with Parkinson's disease. Brozova H; Stochl J; Roth J; Ruzicka E Neuro Endocrinol Lett; 2009; 30(4):453-7. PubMed ID: 20010494 [TBL] [Abstract][Full Text] [Related]
37. Respondent burden and patient-perceived validity of the PDQ-39. Kim MY; Dahlberg A; Hagell P Acta Neurol Scand; 2006 Feb; 113(2):132-7. PubMed ID: 16411975 [TBL] [Abstract][Full Text] [Related]
38. Do metronomes improve the quality of life in people with Parkinson's disease? A pragmatic, single-blind, randomized cross-over trial. Elston J; Honan W; Powell R; Gormley J; Stein K Clin Rehabil; 2010 Jun; 24(6):523-32. PubMed ID: 20483888 [TBL] [Abstract][Full Text] [Related]
39. Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease. Leonardi M; Raggi A; Pagani M; Carella F; Soliveri P; Albanese A; Romito L Parkinsonism Relat Disord; 2012 Jan; 18(1):35-9. PubMed ID: 21880537 [TBL] [Abstract][Full Text] [Related]
40. Rural living and health-related quality of life in Australians with Parkinson's disease. Soh SE; McGinley JL; Watts JJ; Iansek R; Morris ME Rural Remote Health; 2012; 12():2158. PubMed ID: 23234357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]